24/7 Patient Assistance: 760-405-8205

Thomas Lee, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. Thomas Lee, is a renowned medical oncologist in Anaheim, California. He received his medical diploma from Drexel University College of Medicine in 1990. Dr. Lee completed his medical education with a residency in internal medicine at Mayo School of Graduate Medical Education and a fellowship in medical oncology at Scripps Clinic. He is certified by the American Board in medical oncology. His subspecialties are general oncology and hematologic oncology. This doctor works at Kaiser Permanente Anaheim Kraemer Medical Center nd at Kaiser Foundation Hospital Orange County. He was awarded the honor CMS Stage 1 in 2011. He has published 8 articles in collaboration with other doctors.

    Insurance Accepted

    CignaKaiser Permanente

  • Education & Training


    Drexel University College of Medicine

    Medical School


    Mayo School of Graduate Medical Education



    Scripps Clinic


  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Kaiser Permanente Orange County - Anaheim Medical Center

    Languages: English/Spanish

    (714) 644-2000

    3440 E La Palma Ave

    Anaheim, California 92806

    Read More
  • Publications & Memberships

    Dr. Thomas Lee has contributed to 3 publications.

    Major activity of cladribine in patients with de novo B-cell prolymphocytic leukemia.

    Saven A Lee T Schlutz M Jacobs A Ellison D Longmire R Piro L; J Clin Oncol. 1997 Jan .

    See more >>

    Prolonged, complete remission after 2-chlorodeoxyadenosine therapy in a patient with refractory essential mixed cryoglobulinemia.

    Lee TC Miller WE Curd JG Piro LD Saven A; Mayo Clin Proc. 1996 Oct .

    See more >>

    Cladribine and mitoxantrone dose escalation in indolent non-Hodgkin's lymphoma.

    Saven A Lee T Kosty M Piro L; J Clin Oncol. 1996 Jul .

    See more >>